- Home
- CEPU vs ARWR Comparison
CEPU vs ARWR Comparison
Compare CEPU & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- ARWR
- Stock Information
- Founded
- CEPU 1989
- ARWR 2003
- Country
- CEPU Argentina
- ARWR United States
- Employees
- CEPU N/A
- ARWR N/A
- Industry
- CEPU Electric Utilities: Central
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- CEPU Utilities
- ARWR Health Care
- Exchange
- CEPU Nasdaq
- ARWR Nasdaq
- Market Cap
- CEPU 1.6B
- ARWR 1.8B
- IPO Year
- CEPU 2018
- ARWR 1993
- Fundamental
- Price
- CEPU $11.92
- ARWR $13.03
- Analyst Decision
- CEPU Hold
- ARWR Buy
- Analyst Count
- CEPU 1
- ARWR 11
- Target Price
- CEPU $12.00
- ARWR $41.44
- AVG Volume (30 Days)
- CEPU 249.8K
- ARWR 1.6M
- Earning Date
- CEPU 05-12-2025
- ARWR 05-12-2025
- Dividend Yield
- CEPU 2.62%
- ARWR N/A
- EPS Growth
- CEPU N/A
- ARWR N/A
- EPS
- CEPU 0.03
- ARWR N/A
- Revenue
- CEPU $715,974,448.00
- ARWR $2,500,000.00
- Revenue This Year
- CEPU $26.57
- ARWR $4,380.43
- Revenue Next Year
- CEPU N/A
- ARWR $64.24
- P/E Ratio
- CEPU $35.08
- ARWR N/A
- Revenue Growth
- CEPU 8.10
- ARWR N/A
- 52 Week Low
- CEPU $7.07
- ARWR $9.57
- 52 Week High
- CEPU $16.60
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- CEPU 61.06
- ARWR 47.38
- Support Level
- CEPU $10.28
- ARWR $12.44
- Resistance Level
- CEPU $10.75
- ARWR $14.97
- Average True Range (ATR)
- CEPU 0.52
- ARWR 0.74
- MACD
- CEPU 0.12
- ARWR 0.11
- Stochastic Oscillator
- CEPU 97.10
- ARWR 37.01
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.